Study of a new thyroid dosing method for children
Part of Bones, joints & muscles, Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new way to adjust thyroid medication doses for children with either congenital hypothyroidism or Graves' disease. It aims to help find the right dose more easily and improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have congenital hypothyroidism (confirmed by a high TSH level) OR be under 18 with Graves' disease (new, recurring, or not well controlled).
- Your child must be able to attend all scheduled study visits and follow-ups.
- You or your child's legal representative must sign a consent form agreeing to participate.
- Newborns whose mothers have Graves' disease cannot join.
- Children with certain other causes of hyperthyroidism (like toxic nodules, amiodarone use, McCune-Albright syndrome, or genetic causes) cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding vitamin D therapy to the usual Graves' disease treatment (methimazole) can improve thyroid function and lower antibody levels in children. If your child is between 9 and 17 and recently diagnosed, they may be able to participate.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This study compares two types of levothyroxine (a thyroid hormone medicine) to see which works better for newborns and children with congenital hypothyroidism (a condition where the thyroid gland doesn't work properly from birth). If your child was diagnosed early and lives in the Emilia-Romagna region of Italy, this trial may help find the best treatment.
This study tests a computer program called DigiThy that helps doctors adjust your methimazole dose compared to standard care. The goal is to control your thyroid hormone levels more effectively and safely.
This trial uses a special ultrasound to look at blood flow in the thyroid gland, which may help monitor how well treatment for Graves' disease is working in children. It is for children who are newly diagnosed with an overactive thyroid.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
Hear when a new Thyroid Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.